PCN8 COST-EFFECTIVENESS OF ADJUVANT CHEMOTHERAPY WITH URACIL-TEGAFUR, AN ORAL FLUOROPYRIMIDINE DERIVATIVE, IN PATIENTS WITH NON-SMALL-CELL LUNG CANCER IN JAPAN
Abstract
Authors
S Ikeda H Sakamaki S Yajima N Ikegami
S Ikeda H Sakamaki S Yajima N Ikegami
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now